Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 484
1.
Z Rheumatol ; 83(5): 428, 2024 Jun.
Article De | MEDLINE | ID: mdl-38829415
3.
Z Rheumatol ; 83(4): 338, 2024 May.
Article De | MEDLINE | ID: mdl-38683348
4.
Rheum Dis Clin North Am ; 50(1): 93-101, 2024 02.
Article En | MEDLINE | ID: mdl-37973291

Eric Bywaters and Barbara Ansell were, without doubt, two of the giants in the field of Rheumatology. With their keen clinical observations and their visionary development of a dedicated multidisciplinary program focusing on diagnosis, treatment, and research, they are remembered as the founders of the modern specialty of Pediatric Rheumatology.


Rheumatology , History, 20th Century , Humans , Rheumatology/history , Pediatrics
11.
World Neurosurg ; 148: 136-140, 2021 04.
Article En | MEDLINE | ID: mdl-33444823

Jacques Forestier (1890-1978) was a well-known rheumatologist and radiologist whose innovations have revolutionized spinal neurosurgery and rheumatology. He was well known as "Doctor Lipiodol" for his accidental discovery of spinal myelography, which he later extrapolated for use in many body cavities and their pathologies. He was the first to describe "senile ankylosing hyperostosis of the spine," which was later renamed "diffuse idiopathic skeletal hyperostosis." Furthermore, he is credited with the first use of gold salts as a disease-modifying therapy for rheumatoid arthritis. We have presented a historical vignette to chronicle the life of Jacques Forestier and his contributions to the field of spinal neurosurgery.


Neurosurgery/history , Rheumatology/history , Spine/surgery , Arthritis, Rheumatoid/drug therapy , France , Gold Compounds/therapeutic use , History, 20th Century , Humans , Myelography/history , Spine/diagnostic imaging
14.
Z Rheumatol ; 79(10): 1050-1056, 2020 Dec.
Article De | MEDLINE | ID: mdl-32761253

The writer Bertolt Brecht (1898-1956) is known for his poems, dramas and the "epic or dialectical theater" he founded. He was retrospectively postulated to have had rheumatic fever because of heart problems and neuromuscular symptoms in his youth. Based on current rheumatological knowledge, it cannot be deduced with certainty from the available documents that Brecht had rheumatic fever. At most, a very unusual manifestation of rheumatic fever can be suspected with atypical rheumatic chorea and a very atypical course of rheumatic carditis. Several deviations from the classical clinical picture-the absence of fever and arthritis, no typical symptoms of Sydenham's chorea, the lack of a diagnosis of heart valve defects in adolescence-lead to extensive differential diagnostic considerations. A possible psychosomatic origin through functional heart complaints must even be postulated if a temporary previous organic cause cannot be excluded. Only the use of the advanced diagnostics available today with Doppler sonography of the heart, cardiac magnetic resonance imaging (MRI), throat swabs for Streptococci and streptococcal serology would have made it possible to diagnose Brecht's cardiac symptoms in his adolescence without a doubt and to differentiate them from functional heart complaints. His death is verified by medical documents clearly documenting bacterial endocarditis with evidence of coli bacteria caused by urological interventions with subsequent febrile episodes and pyelonephritis.


Rheumatic Fever , Rheumatology/history , Adolescent , Chorea/diagnosis , Diagnosis, Differential , History, 19th Century , History, 20th Century , Humans , Male , Retrospective Studies , Rheumatic Fever/diagnosis , Rheumatic Heart Disease/diagnosis
15.
Hist Philos Life Sci ; 42(3): 35, 2020 Aug 06.
Article En | MEDLINE | ID: mdl-32761389

Since the arrival of Translational Medicine (TM), as both a term and movement in the late 1990s, it has been associated almost exclusively with attempts to accelerate the "translation" of research-laboratory findings to improve efficacy and outcomes in clinical practice (Krueger et al. in Hist Philos Life Sci 41:57, 2019). This framing privileges one source of change in medicine, that from bench-to-bedside. In this article we dig into the history of translation research to identify and discuss three other types of translational work in medicine that can also reshape ideas, practices, institutions, behaviours, or all of these, to produce transformations in clinical effectiveness. These are: (1) making accessible state-of-the-art knowledge and best practice across the medical profession; (2) remodelling and creating institutions to better develop and make available specialist knowledge and practice; and (3) improving public and patient understandings of disease prevention, symptoms and treatments. We do so by examining the work of William S. C. Copeman, a dominant figure in British rheumatology from the 1930 through the late 1960s. Throughout his long career, Copeman blended approaches to "translation" in order to produce transformative change in clinical medicine, making his work an exemplar of our expanded notion of TM.


Rheumatology/history , Translational Research, Biomedical/history , England , History, 20th Century , Humans
18.
Rheumatol Int ; 40(2): 175-182, 2020 Feb.
Article En | MEDLINE | ID: mdl-31898762

Rheumatology in Ukraine is based on established research and clinical infrastructure that enable the integration with regional and global societies. This article overviews current state of Ukrainian rheumatology, important steps toward expanding clinical settings, and opportunities for strengthening cooperation of local rheumatologists and patients with rheumatic diseases with related international societies. The main achievements and some challenges encountered by the Association of Rheumatologists of Ukraine are outlined. The Association supports continuing medical education of local specialists and explores options for advancing research and publishing in rheumatology. One of the main challenges still remains the creation of registries of patients with rheumatic diseases and expansion of activities of public societies with interest in combating rheumatic diseases. The issue of inadequate access to immunobiological therapies is also highlighted.


Rheumatic Diseases/epidemiology , Rheumatologists/supply & distribution , Rheumatology , Antirheumatic Agents/therapeutic use , History, 19th Century , History, 20th Century , History, 21st Century , Humans , Periodicals as Topic , Practice Guidelines as Topic , Rheumatic Diseases/therapy , Rheumatology/education , Rheumatology/history , Societies, Medical , Ukraine/epidemiology
...